• Estimated total population:1
    44.3 million
  • Maternal mortality ratio:2
    360 per 100,000 live births
  • Infant mortality rate:2
    49 per 1,000 live births
  • Under-five mortality rate:2
    73 per 1,000 live births
  • Total fertility rate:1
  • Contraceptive prevalence:1
    58% (all methods)
    53% (modern methods)
  • HIV prevalence:3
  • Births with skilled provider:2
  • Sources:
  • 1 Population Reference Bureau 2015 World Population Data Sheet;
  • 2 Kenya statistics on UNICEF website;
  • 3 UNAIDS 2013 Report on the Global AIDS Epidemic.


Jhpiego’s program in Kenya, currently with nearly 200 staff, is one of Jhpiego’s largest and oldest. After an early focus on family planning and reproductive health, Jhpiego subsequently expanded its portfolio in Kenya by providing technical expertise in other areas such as maternal and child health, malaria, HIV/AIDS and tuberculosis.

Jhpiego’s programs that are currently active in Kenya include:

  • APHIAplus Zone 4 (APHIAplus KAMILI), funded by the U.S. Agency for International Development (USAID)
  • APHIAplus Zone 1 (APHIAplus Western Kenya), also funded by USAID, as a sub-grantee to PATH
  • The USAID-funded Maternal and Child Survival Program
  • The Kenya Urban Reproductive Health Initiative, funded by the Bill & Melinda Gates Foundation
  • Brighter Future, a grant from Merck & Co.
  • The Heart Program, funded by AstraZeneca
  • Advance Family Planning (AFP2) Project
  • Accelerating Scale-up of Implants, funded by the Bill & Melinda Gates Foundation

For a full description of these initiatives and Jhpiego’s partnerships in Kenya, click the link below.

For additional information, please visit the Jhpiego Kenya website at:

Kenya Country Profile.pdf783.14 KB

Sign Up

Copyright © 2000-2016 Jhpiego Corporation. All rights reserved.
Web Policy | Site Map | E-mail Us